Early Gastric Cancer in China: Real-World Outcomes by Treatment Type
Official title: Establishing an Innovative Cohort for Chinese Early Gastric Cancer Patients Based on the National Clinical Research Center for Digestive Diseases Prospective Database: A Retrospective Study
Run by Beijing Friendship Hospital · NCT07747688 · Data updated 2026-11-12
This project will look at real-world outcomes for about 5,000 Chinese patients with early gastric cancer treated with endoscopic resection, laparoscopic surgery, open surgery, or a combined approach to see how treatments relate to survival and recurrence.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Beijing Friendship Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | May 8, 2026 |
| Main results expected | May 8, 2027 |
| Study ends | June 8, 2027 |
| Registry record updated | August 5, 2026 |
| Trial ID | NCT07747688 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–90 with histopathologically confirmed early gastric cancer (cT1NxM0) who received primary treatment at Beijing Friendship Hospital and provided broad informed consent.
✕Probably not a fit
Patients with incomplete data, indeterminate preoperative classification, or significant loss to follow-up may not benefit from the study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a retrospective observational study using a large prospective clinical database to describe clinicopathological features, treatment patterns, and long-term outcomes of early gastric cancer in China. It will compare overall survival and disease-free survival across treatment modalities and identify factors that influence prognosis. Data will be drawn from patients treated at Beijing Friendship Hospital who meet predefined eligibility criteria and have signed informed consent. The study will exclude patients with incomplete data, indeterminate preoperative classification, or loss to follow-up. Findings may help refine real-world treatment decisions for early gastric cancer.
Why it matters
Potential benefit: If successful, the study could clarify which treatment approaches are associated with better long-term outcomes in real-world Chinese practice.
How similar studies have gone: Prior studies in similar settings have shown valuable insights from real-world data, but this analysis focuses on a large Chinese cohort with multiple treatment modalities.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients aged between 18 and 90 years; * preoperative endoscopic biopsy-confirmed gastric adenocarcinoma; * clinical stage early gastric (cT1NxM0) cancer according to the AJCC 8th edition TNM staging system; * patients who have signed a broad informed consent. * Received primary treatment (including endoscopic resection, laparoscopic surgery, open surgery, or combined laparoscopic-endoscopic approach) at Beijing Friendship Hospital. Exclusion Criteria: * pregnant or breastfeeding women; * Preoperative or intraoperative diagnosis remained indeterminate due to insufficient pathological or imaging evidence, such that the patient could not be clearly classified as early gastric cancer prior to treatment; * Critical clinical data were severely incomplete or missing; * Completely lost to follow-up with no available information to confirm survival status.
Where it's running
-
Beijing Friendship Hospital, Capital Medical University
Beijing, China Recruiting
Study contacts
- Study coordinator: Zhi Zheng, Attending surgon
- Email: zhengzhi@ccmu.edu.cn
- Phone: +86-13811132175
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SPADE procedure for upper stomach cancer
A multicenter study will test the SPADE operation, a special stomach reconnection technique, in patients with early upper-stomach cancer undergoing proximal gastrectomy to see if it is safe and feasible.
-
LECS with sentinel node navigation for early gastric cancer
This study tests whether combining LECS with sentinel node navigation can treat early gastric cancer while preserving stomach function in eligible patients.
-
Image-guided platform helps find sentinel lymph nodes in early gastric cancer
This study tests whether an image-guided platform with a deep learning model can find and retrieve sentinel lymph nodes better than standard palpation in people with early gastric cancer undergoing LECS-SNNS.
-
H. pylori status and tissue features to predict gastric cancer behavior after endoscopic treatment
This study tests whether current H. pylori infection status and tissue features can help predict how early gastric cancer will behave after endoscopic treatment.
-
Dual-endoscope Sentinel Lymph Node Navigation for Early Gastric Cancer
This study tests whether using two endoscopes to guide sentinel lymph node navigation during laparoscopic surgery is safe and effective for people with early gastric cancer who need additional surgery after initial endoscopic treatment.
-
Explainable multimodal AI for diagnosing early gastric cancer from endoscopic images
This project will try an explainable AI that combines white-light and image-enhanced endoscopy pictures plus clinical data to help detect early gastric cancer in adults with suspicious gastric lesions who underwent endoscopic submucosal dissection.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.